Relationship of endotoxin to tumor necrosis factor-α and interleukin- 1β in children with otitis media with effusion

Annals of Otology, Rhinology and Laryngology

Volumn 107, Issue 1, 1998, Pages 28-33

  Willett, Darryl N ^a   Rezaee, Rod P ^a   Tighe, Mary B ^a   Billy, John M ^a   Demaria, Thomas F ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Bilateral tympanostomy tube insertion; Enzyme linked immunosorbent assay; Limulus amebocyte lysate assay; Middle ear effusion

Indexed keywords

CHROMOGENIC SUBSTRATE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; LIMULUS LYSATE TEST; MALE; MIDDLE EAR EFFUSION; PRIORITY JOURNAL; SECRETORY OTITIS MEDIA;

EID: 0031962239     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949810700106     Document Type: Article

References (19)

1. Hitchcock PJ, Leive L, Makela H, Rietschel ET, Strittmatter W, Morrison DC. Lipopolysaccharide nomenclature -past, present, and future. J Bacteriol 1986;166:699-705.
2. Gu XX, Tsai CM, Apicella A, Lim D. Quantitation and biological properties of released and cell-bound lipooligosaccharides from nontypeable Hacmophilus infiuenzae. Infect Immun 1995;63:4115-20.
3. DeMaria TR Prior RB, Briggs BR, Lim DJ, Birck HG. Endotoxin in middle ear effusions from patients with chronic otitis media with effusion. J Clin Microbiol 1984;20:15-7.
4. Rietschel ET, Brade H. Bacterial endotoxins. Sci Am 1992;267:54-61.
5. Nonomura N. Otitis media with effusion following inoculation of H influenzae type b endotoxin. Arch Otorhinolaryngol 1986;243:31-5.
6. Yellon RF, Leonard G, Marucha PT, et al. Characterization of cytokines present in middle ear effusions. Laryngoscope 1991;101:165-9.
7. Ophir D, Hahn T, Schattner A, Wallach D, Aviel A. Tumor necrosis factor in middle ear effusions. Arch Otolaryngol Head Neck Surg 1988;114:1256-8.
8. DeMaria TF. Endotoxin and otitis media. Ann Otol Rhinol Laryngol Suppl 1988;97(suppl 132):31-3.
9. Juhn SK, Garvis WJ, Lees CJ, Le CT, Kim CS. Determining otitis media severity from middle ear fluid analysis. Ann Otol Rhinol Laryngol Suppl 1994;103(suppl 163):43-5.
10. Lewis DM, Schram JL. Lim DJ. Techniques for the preparation of smears from middle ear effusions for cytologie analysis. In: Wiet RF, Coulthard SW, eds. Proceedings of the Second Conference on Otitis Media. Columbus, Ohio: Ross Laboratories, 1979:35-9.
11. Kawauchi H, DeMaria TF, Lim DJ. Endotoxin permeability through the round window. Acta Otolaryngol Suppl (Stockh) 1988(suppl 457):100-15.
12. Elin RJ, Wolff SN. Nonspecificity of the limulus amebocyte lysate test: positive reactions with polynucleotides and proteins. J Infect Dis 1973;128:349-52.
13. Cooperstock MS, Tucker RP, Baublis JV. Possible pathogenic role of endotoxin in Reye's syndrome. Lancet 1975;1: 1272-4.
14. Bradford M. A rapid and sensitive method for the quan-titation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
15. Popham WJ, Sirotnik KA. Understanding statistics in education. Itasca, III: FE Peacock, 1992:68-73.
16. Omen MJ, Baldwin CD, Swank PR, Pannua AK, Johnson DL, Howie VM. Relation of infant feeding practices, cigarette smoke exposure, and group child care to the onset and duration of otitis media with effusion in the first two years of life. J Pediatr 1993;123:702-11.
17. Daly KA. Epidemiology of otitis media. Otolaryngol Clin North Am 1991;24:775-86.
18. Yellon RF, Doyle WJ, Whiteside TL, Diven WF, March AR, Fireman P. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusion. Arch Otolaryngol Head Neck Surg 1995;121:865-9.
19. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.